Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Maher

Showing results (1061-1070 of 1,158) with videos related to

Pageof 116
Sort By:
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 1, 1997
The outcome of unrelated donor bone marrow transplantation in patients with hematologic malignancies using tacrolimus (FK506) and low dose methotrexate for graft-versus-host disease prophylaxisS M Devine, R B Geller, L B Lin, et al.
ERJ Open Research|October 27, 2018
Safety and tolerability of nintedanib for the treatment of idiopathic pulmonary fibrosis in routine UK clinical practiceSophie V Fletcher, Mark G Jones, Elizabeth A Renzoni, et al.
ERJ Open Research|February 18, 2026
Prognostic biomarkers for idiopathic pulmonary fibrosis: findings from ISABELA clinical trialsMatthew J Randall, Claus A Andersen, Kevin K Brown, et al.
Respirology (Carlton, Vic.)|December 26, 2022
MUC5B rs35705950 minor allele associates with older age and better survival in idiopathic pulmonary fibrosisJoanne J van der Vis, Antje Prasse, Elisabetta A Renzoni, et al.
The Lancet. Respiratory Medicine|March 16, 2015
Longitudinal change in collagen degradation biomarkers in idiopathic pulmonary fibrosis: an analysis from the prospective, multicentre PROFILE studyR Gisli Jenkins, Juliet K Simpson, Gauri Saini, et al.
American Journal of Respiratory and Critical Care Medicine|February 29, 2024
Machine Learning of Plasma Proteomics Classifies Diagnosis of Interstitial Lung DiseaseYong Huang, Shwu-Fan Ma, Justin M Oldham, et al.
Frontiers in Pharmacology|May 2, 2025
Bee venom ameliorates gentamicin-induced kidney injury by restoring renal aquaporins and enhancing antioxidant and anti-inflammatory activities in ratsDoaa Abdelrahaman, Obeid Shanab, Ahmed Abdeen, et al.
American Journal of Respiratory and Critical Care Medicine|January 5, 2022
Candidate Role for Toll-like Receptor 3 L412F Polymorphism and Infection in Acute Exacerbation of Idiopathic Pulmonary FibrosisAoife N McElroy, Rachele Invernizzi, Joanna W Laskowska, et al.
Journal of Perinatology : Official Journal of the California Perinatal Association|January 6, 2026
Development of a prediction model for mortality in infants undergoing therapeutic hypothermia for neonatal encephalopathyJill M Mitchell, Clare L Rodrigues, Margo Dunworth, et al.
American Journal of Respiratory and Critical Care Medicine|March 14, 2024
Phase 2, Double-Blind, Placebo-controlled Trial of a c-Jun N-Terminal Kinase Inhibitor in Idiopathic Pulmonary FibrosisWaldo L L D Mattos, Nasreen Khalil, Lisa G Spencer, et al.
Pageof 116

Showing results (1061-1070 of 1,158) with videos related to

Sort By:
Pageof 116
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 1, 1997
The outcome of unrelated donor bone marrow transplantation in patients with hematologic malignancies using tacrolimus (FK506) and low dose methotrexate for graft-versus-host disease prophylaxisS M Devine, R B Geller, L B Lin, et al.
ERJ Open Research|October 27, 2018
Safety and tolerability of nintedanib for the treatment of idiopathic pulmonary fibrosis in routine UK clinical practiceSophie V Fletcher, Mark G Jones, Elizabeth A Renzoni, et al.
ERJ Open Research|February 18, 2026
Prognostic biomarkers for idiopathic pulmonary fibrosis: findings from ISABELA clinical trialsMatthew J Randall, Claus A Andersen, Kevin K Brown, et al.
Respirology (Carlton, Vic.)|December 26, 2022
MUC5B rs35705950 minor allele associates with older age and better survival in idiopathic pulmonary fibrosisJoanne J van der Vis, Antje Prasse, Elisabetta A Renzoni, et al.
The Lancet. Respiratory Medicine|March 16, 2015
Longitudinal change in collagen degradation biomarkers in idiopathic pulmonary fibrosis: an analysis from the prospective, multicentre PROFILE studyR Gisli Jenkins, Juliet K Simpson, Gauri Saini, et al.
American Journal of Respiratory and Critical Care Medicine|February 29, 2024
Machine Learning of Plasma Proteomics Classifies Diagnosis of Interstitial Lung DiseaseYong Huang, Shwu-Fan Ma, Justin M Oldham, et al.
Frontiers in Pharmacology|May 2, 2025
Bee venom ameliorates gentamicin-induced kidney injury by restoring renal aquaporins and enhancing antioxidant and anti-inflammatory activities in ratsDoaa Abdelrahaman, Obeid Shanab, Ahmed Abdeen, et al.
American Journal of Respiratory and Critical Care Medicine|January 5, 2022
Candidate Role for Toll-like Receptor 3 L412F Polymorphism and Infection in Acute Exacerbation of Idiopathic Pulmonary FibrosisAoife N McElroy, Rachele Invernizzi, Joanna W Laskowska, et al.
Journal of Perinatology : Official Journal of the California Perinatal Association|January 6, 2026
Development of a prediction model for mortality in infants undergoing therapeutic hypothermia for neonatal encephalopathyJill M Mitchell, Clare L Rodrigues, Margo Dunworth, et al.
American Journal of Respiratory and Critical Care Medicine|March 14, 2024
Phase 2, Double-Blind, Placebo-controlled Trial of a c-Jun N-Terminal Kinase Inhibitor in Idiopathic Pulmonary FibrosisWaldo L L D Mattos, Nasreen Khalil, Lisa G Spencer, et al.
Pageof 116